- Supernus Pharmaceuticals (NASDAQ:SUPN): Q2 EPS of $0.18 beats by $0.05.
- Revenue of $50.4M (+43.8% Y/Y) beats by $0.73M.
- Press Release
Supernus Pharmaceuticals beats by $0.05, beats on revenue
Recommended For You
About SUPN Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| SUPN | - | - |
| Supernus Pharmaceuticals, Inc. | ||